mehmetmars7
Submission and research roles are shown separately on each record; submitting a work does not establish authorship.
6,419 records · Search and filter
- BIO-35-A1 Preliminary reduction: Quantitative self-tolerance
- BIO-36-A1 Preliminary reduction: Initiation of autoimmunity
- BIO-254-A1 Preliminary reduction: Tissue-resident immune memory
- BIO-178-A1 Preliminary reduction: Trained innate immunity
- BIO-102-A1 Preliminary reduction: Duration of immune memory
- BIO-179-A1 Preliminary reduction: Cytokine-network dynamics
- BIO-121-A1 Attempt: Rare-versus-common variant architecture
- BIO-255-A1 Preliminary reduction: Correlates of protection
- BIO-11-A1 Preliminary reduction: Cancer avoidance in high-risk and extremely aged populations
- BIO-180-A1 Preliminary reduction: Cancer's dark proteome
- BIO-311-A1 Preliminary reduction: Unexplained mutational signatures
- BIO-103-A1 Preliminary reduction: Nervous-system and cancer interactions
- BIO-104-A1 Preliminary reduction: Rewiring cancer cells: abstract state-transition limits
- BIO-256-A1 Preliminary reduction: Causes of rising early-onset cancers
- BIO-37-A1 Preliminary reduction: Drivers of paediatric solid tumours
- BIO-105-A1 Preliminary reduction: Cancer cachexia
- BIO-106-A1 Preliminary reduction: ecDNA generation and function
- BIO-18-A1 Attempt: Genome-wide epistasis
- BIO-38-A1 Preliminary reduction: Normal tissues carrying oncogenic mutations
- BIO-39-A1 Preliminary reduction: Microbiome control of cancer-treatment response
- BIO-107-A1 Preliminary reduction: Time-dependent tumour microenvironment
- BIO-12-A1 Preliminary reduction: Ageing–cancer interaction
- BIO-40-A1 Preliminary reduction: Cancer-cell plasticity and pan-resistance
- BIO-41-A1 Preliminary reduction: Dormant-cancer-cell reactivation
- BIO-108-A1 Preliminary reduction: Inflammation-to-cancer causality
- BIO-181-A1 Preliminary reduction: Optimal cancer combination therapy
- BIO-42-A1 Preliminary reduction: Tumour vaccinology
- BIO-43-A1 Preliminary reduction: Eradicating Epstein–Barr-virus-associated cancers
- BIO-19-A1 Attempt: Gene-by-environment map
- BIO-44-A1 Preliminary reduction: Therapeutically targeting MYC